EconPapers    
Economics at your fingertips  
 

Role of NLRP3 Inflammasome Activation in Obesity-Mediated Metabolic Disorders

Kaiser Wani, Hind AlHarthi, Amani Alghamdi, Shaun Sabico and Nasser M. Al-Daghri
Additional contact information
Kaiser Wani: Biochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia
Hind AlHarthi: Biochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia
Amani Alghamdi: Biochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia
Shaun Sabico: Biochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia
Nasser M. Al-Daghri: Biochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia

IJERPH, 2021, vol. 18, issue 2, 1-21

Abstract: NLRP3 inflammasome is one of the multimeric protein complexes of the nucleotide-binding domain, leucine-rich repeat (NLR)-containing pyrin and HIN domain family (PYHIN). When activated, NLRP3 inflammasome triggers the release of pro-inflammatory interleukins (IL)-1β and IL-18, an essential step in innate immune response; however, defective checkpoints in inflammasome activation may lead to autoimmune, autoinflammatory, and metabolic disorders. Among the consequences of NLRP3 inflammasome activation is systemic chronic low-grade inflammation, a cardinal feature of obesity and insulin resistance. Understanding the mechanisms involved in the regulation of NLRP3 inflammasome in adipose tissue may help in the development of specific inhibitors for the treatment and prevention of obesity-mediated metabolic diseases. In this narrative review, the current understanding of NLRP3 inflammasome activation and regulation is highlighted, including its putative roles in adipose tissue dysfunction and insulin resistance. Specific inhibitors of NLRP3 inflammasome activation which can potentially be used to treat metabolic disorders are also discussed.

Keywords: NLRP3 inflammasome; metabolic stress; insulin resistance; diabetes; obesity (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/18/2/511/pdf (application/pdf)
https://www.mdpi.com/1660-4601/18/2/511/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:18:y:2021:i:2:p:511-:d:477765

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().

 
Page updated 2025-03-19
Handle: RePEc:gam:jijerp:v:18:y:2021:i:2:p:511-:d:477765